marketcaparena

LIMN

Liminatus Pharma, Inc.

Company overview

Market capitalization
$281.74M
Employees
1
Latest publication
2026-09-29
About Liminatus Pharma, Inc.

Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial for the treatment of advanced solid cancers, including non-small cell lung cancer. The company was founded in 2018 and is based in Cerritos, California.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Revenue0USD0USD0USD—0USD0USD——
Cost Of Revenue518USD—542USD—————
Gross Profit-518USD—-542USD—————
Research Development400,000USD0USD0USD—0USD200USD357,066USD714,134USD
Selling General Administrative700,898USD884,211USD701,170USD—264,220USD167,000USD186,081USD195,084USD
Total Operating Expenses1,100,898USD884,211USD701,170USD—255USD522,788USD1,019,694USD642,082USD
Operating Income-1,100,898USD-884,211USD-701,170USD—-255USD-522,788USD-1,019,694USD-642,082USD
Interest Income0USD0USD0USD—52,206USD43,526USD34,481USD—
Interest Expense18,638USD19,051USD19,052USD—115,512USD136,763USD92,706USD77,220USD
Net Interest Income-18,638USD-19,051USD-19,052USD—-63,306USD-62,356USD-58,225USD—
Income Before Tax-1,123,714USD-8,168,927USD-1,823,351USD—-255USD-865,263USD-637,737USD-530,074USD
Net Income-1,123,714USD-8,168,927USD-1,823,351USD—-255USD-868,314USD-642,900USD-534,854USD
Net Income From Continuing Ops-1,123,714USD-8,168,927USD-1,823,351USD—-255USD-229,309USD-601,372USD—
Ebitda-1,100,898USD-8,149,333USD-1,803,757USD—-255USD-728,500USD-637,737USD-530,074USD
Reconciled Depreciation518USD543USD542USD743USD0USD—0USD—
Total Other Income Expense Net-22,816USD-7,284,716USD-1,122,181USD——-342,474USD381,957USD112,008USD
Ebit—-8,149,876USD-1,804,299USD—————
Depreciation And Amortization—543USD542USD—————
Income Tax Expense—————3,051USD5,163USD4,780USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
Total Revenue0USD0USD0USD0USD—
Research Development0USD2,685,000USD3,757,000USD1,853,000USD3,802,000USD
Selling General Administrative2,967,812USD645,000USD1,062,000USD856,000USD197,000USD
Total Operating Expenses2,967,812USD2,906,319USD2,586,211USD2,709,000USD2,534,272USD
Operating Income-2,967,812USD-2,906,319USD-2,586,211USD-2,709,000USD-2,534,272USD
Interest Income76,589USD122,526USD10,000USD0USD—
Interest Expense215,903USD138,102USD175,000USD219,000USD—
Net Interest Income-139,314USD-216,356USD-165,000USD-219,000USD—
Income Before Tax-10,206,517USD-2,885,458USD-1,192,231USD-2,928,000USD4,369,659USD
Net Income-10,206,517USD-2,904,299USD-1,226,218USD-2,928,000USD4,369,659USD
Net Income From Continuing Ops-10,206,517USD-3,546,309USD-4,984,000USD-2,928,000USD—
Ebit-9,990,614USD————
Ebitda-9,988,786USD-2,747,356USD-1,089,142USD-2,709,000USD4,369,658USD
Depreciation And Amortization1,828USD————
Reconciled Depreciation1,828USD0USD———
Total Other Income Expense Net-7,238,705USD20,861USD1,393,980USD-219,000USD6,903,931USD
Income Tax Expense—18,841USD33,987USD539,823USD—
Unclassified Operating Expenses——-2,232,789USD—-1,464,728USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Assets3,403,702USD2,790,249USD512,795USD1,342,409USD2,828,932USD5,408,859USD3,068,186USD3,535,705USD
Total Current Assets3,392,467USD2,778,546USD500,574USD1,203,370USD812,658USD5,281,643USD394,187USD409,159USD
Other Current Assets375,371USD870,872USD162,919USD478,868USD1,664USD155,501USD20,250USD45,500USD
Total Liabilities3,103,090USD———————
Total Current Liabilities3,040,423USD2,889,423USD10,298,241USD2,864,593USD1,060USD24,748,922USD7,535,622USD6,468,698USD
Total Stockholder Equity300,612USD-132,596USD-9,814,690USD-1,645,763USD-1,060USD-19,340,063USD-14,254,998USD-13,069,526USD
Total Equity Including Noncontrolling Interest300,612USD———————
Property Plant Equipment Net11,235USD11,703USD12,221USD12,764USD—941USD1,000USD—
Accounts Payable655,089USD529,778USD582,234USD559,171USD—1,483,253USD1,172,000USD—
Common Stock5,597USD4,823USD2,706USD2,706USD1,757,158USD—2,452,853USD2,921,999USD
Retained Earnings-41,402,706USD-39,995,447USD-38,871,733USD-30,702,806USD-1,060USD-28,665,216USD-16,642,468USD-15,994,197USD
Total Liab—2,922,845USD10,327,485USD2,988,172USD1,060USD24,748,922USD17,323,184USD16,605,231USD
Other Current Liab—1,446,923USD8,855,741USD862,922USD1,060USD—2,963,402USD2,696,478USD
Capital Stock—4,823USD2,706USD2,706USD0USD1,750USD——
Cash—1,907,674USD337,655USD724,502USD804,538USD56,319USD358,181USD339,203USD
Cash And Short Term Investments—1,907,674USD337,655USD724,502USD804,538USD—358,181USD339,203USD
Net Debt—-465,174USD1,104,845USD717,998USD4,317,682USD19,916,681USD4,214,039USD3,433,017USD
Short Term Debt—1,442,500USD1,442,500USD1,442,500USD5,122,220USD—4,572,220USD3,772,220USD
Short Long Term Debt—1,442,500USD1,442,500USD1,442,500USD—19,973,000USD19,273,000USD—
Short Long Term Debt Total—1,442,500USD1,442,500USD1,442,500USD5,122,220USD—4,572,220USD3,772,220USD
Common Stock Shares Outstanding—23,753,561shares23,753,561shares27,007,568shares27,064,600shares7,074,477shares7,173,964shares7,187,037shares
Non Current Assets Total—11,703USD12,221USD139,039USD2,016,274USD127,216USD2,673,999USD3,126,546USD
Non Current Liabilities Total—33,422USD29,244USD123,579USD10,017,399USD0USD9,787,562USD10,136,533USD
Net Working Capital—-110,877USD-9,797,667USD-1,661,223USD—-19,467,279USD-19,238,000USD—
Unclassified Current Liabilities—-1,972,278USD-2,024,734USD-1,442,500USD-5,122,220USD3,292,669USD-20,445,000USD—
Unclassified Equity—39,853,205USD29,051,631USD29,051,631USD-1,757,148USD9,323,403USD——
Non Currrent Assets Other———126,275USD——-2,547,999USD—
Net Receivables————6,456USD—15,756USD24,456USD
Accumulated Other Comprehensive Income————-10USD—-117,669USD-68,888USD
Unclassified Non Current Assets————2,016,274USD—2,672,999USD3,126,546USD
Unclassified Non Current Liabilities————10,017,399USD—9,787,562USD10,136,533USD
Unclassified Current Assets—————5,069,823USD——
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
Total Assets512,795USD2,828,932USD4,502,213USD15,488,270USD276,438,764USD
Other Current Assets162,919USD1,664USD-1,168,119USD-4,787,351USD84,438USD
Total Liab10,327,485USD18,698,831USD15,194,997USD14,194,064USD21,569,899USD
Total Stockholder Equity-9,814,690USD-15,869,899USD-10,692,784USD1,294,206USD254,868,865USD
Other Current Liab8,855,741USD2,075,211USD-11,824,447USD-13,416,582USD871,389USD
Common Stock2,706USD1,757,158USD4,050,340USD15,128,311USD276,000,690USD
Capital Stock2,706USD1,750USD———
Retained Earnings-38,871,733USD-17,518,175USD-14,883,124USD-13,974,105USD-21,131,825USD
Cash337,655USD804,538USD434,000USD5,048,000USD336,228USD
Cash And Short Term Investments337,655USD804,538USD434,000USD5,048,000USD336,228USD
Total Current Assets500,574USD812,658USD210,881USD360,649USD421,922USD
Total Current Liabilities10,298,241USD8,681,431USD5,158,553USD3,591,418USD1,380,389USD
Net Debt1,104,845USD4,317,682USD15,616,000USD11,452,000USD-246,228USD
Short Term Debt1,442,500USD5,122,220USD16,050,000USD16,500,000USD90,000USD
Short Long Term Debt1,442,500USD19,973,000USD16,050,000USD16,500,000USD—
Short Long Term Debt Total1,442,500USD5,122,220USD16,050,000USD16,500,000USD90,000USD
Accounts Payable582,234USD1,484,000USD933,000USD508,000USD419,000USD
Property Plant Equipment Net12,221USD941USD1,000USD1,000USD—
Common Stock Shares Outstanding23,753,561shares7,191,610shares8,012,534shares34,428,255shares34,500,000shares
Non Current Assets Total12,221USD2,016,274USD4,291,332USD15,127,621USD276,016,842USD
Non Current Liabilities Total29,244USD10,017,399USD10,036,444USD10,602,646USD20,189,510USD
Net Working Capital-9,797,667USD-19,467,279USD-15,795,000USD-10,811,000USD—
Unclassified Current Liabilities-2,024,734USD-19,973,000USD-27,874,447USD-29,916,582USD—
Unclassified Equity29,051,631USD————
Net Receivables—6,456USD945,000USD100,000USD1,256USD
Accumulated Other Comprehensive Income—-160,677USD———
Unclassified Non Current Assets—2,015,333USD4,290,332USD15,126,621USD276,016,842USD
Unclassified Non Current Liabilities—10,017,399USD10,036,444USD10,602,646USD20,189,510USD
Non Currrent Assets Other——-1,000USD-1,000USD—
Unclassified Current Assets——-1,168,119USD-4,787,351USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow YTD

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USD
Depreciation986USD
Change To Liabilities-294,084USD
Change In Working Capital-506,536USD
Operating Cash Flow-2,985,288USD
Financing Cash Flow5,664,729USD
Change In Cash2,679,441USD
End Cash Flow3,017,096USD
SourceDisclosureDeterministicFinal

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-1,123,714USD-8,168,927USD-1,823,351USD—-255USD-868,314USD-642,900USD-534,854USD
Depreciation518USD543USD542USD743USD0USD—0USD—
Other Non Cash Items4,178USD15,274,752USD1,103,129USD—255USD205,711USD-481,708USD-112,008USD
Change In Working Capital-896,271USD-7,493,215USD119,068USD-7,661,093USD255USD-122,892USD395,253USD-41,028USD
Total Cash From Operating Activities-2,015,289USD-386,847USD-600,612USD-8,816,466USD-159,393USD-785,495USD-729,355USD-687,890USD
Capital Expenditures0USD0USD-13,108USD0USD0USD-5USD-5USD-3USD
Free Cash Flow-2,015,289USD-386,847USD-613,720USD-8,816,466USD-159,393USD-785,500USD-729,360USD-687,890USD
Net Borrowings0USD0USD0USD2,327,000USD713,000USD-2,296,077,000USD983,000USD—
Total Cash From Financing Activities3,585,308USD0USD11,032,762USD10,319,762USD713,000USD550,000USD262,800USD-465,669USD
Change In Cash1,570,019USD-386,847USD-613,720USD1,303,296USD-21,393USD446,357USD18,978USD-1,128,003USD
Begin Period Cash Flow337,655USD724,502USD1,338,222USD34,926USD201,537,000USD358,181USD339,203USD1,467,206USD
End Period Cash Flow1,907,674USD337,655USD724,502USD1,338,222USD1,338,222USD804,538USD358,181USD339,203USD
Other Cashflows From Financing Activities3,585,308USD—2,563,738USD—————
Total Cashflows From Investing Activities—-775,000USD-13,108USD——-57,343USD485,533USD1,291,225USD
Issuance Of Capital Stock—0USD0USD———0USD—
Investments——-13,108USD———-800,000USD—
Other Cashflows From Investing Activities——-775,000USD——-1,802,869USD537,200USD1,265,669USD
Unclassified Financing Cash Flow——8,469,024USD7,992,762USD—2,296,627,000USD——
Unclassified Operating Cash Flow———-1,156,116USD————
Change To Account Receivables—————9,300USD8,700USD10,900USD
Unclassified Investing Cash Flow—————1,745,531USD——
Sale Purchase Of Stock——————-537,200USD-1,265,669USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
Net Income-10,206,517USD-2,904,299USD-4,984,000USD-2,928,000USD4,369,659USD
Depreciation1,828USD0USD———
Other Non Cash Items7,225,666USD-157,624USD—900,000USD-6,903,931USD
Change To Account Receivables-3,427,000USD48,000USD———
Change In Working Capital-6,984,295USD-44,539USD1,639,000USD1,159,000USD1,318,393USD
Total Cash From Operating Activities-9,963,318USD-3,106,462USD-3,345,000USD-869,000USD-1,215,879USD
Capital Expenditures-13,108USD0USD0USD0USD0USD
Free Cash Flow-9,976,426USD-3,106,460USD-3,345,000USD-869,000USD-1,215,880USD
Total Cashflows From Investing Activities-788,108USD1,968,249USD-819,000USD263,963,913USD-276,000,000USD
Net Borrowings3,040,000USD3,923,000USD-450,000USD2,417,000USD—
Total Cash From Financing Activities11,032,762USD1,047,131USD-450,000USD5,917,000USD277,552,107USD
Issuance Of Capital Stock10,556,500USD0USD0USD4,200,000USD—
Change In Cash281,336USD648,113USD-4,614,000USD5,048,000USD336,228USD
Begin Period Cash Flow56,319USD156,425USD5,048,000USD336,228USD—
End Period Cash Flow337,655USD804,538USD434,000USD5,048,000USD336,228USD
Other Cashflows From Investing Activities-5,218,500USD-189,139USD-698,484USD-15,127,621USD—
Other Cashflows From Financing Activities-2,563,738USD-1,047,131USD10,657,185USD-268,840,913USD-5,520,000USD
Unclassified Investing Cash Flow4,443,500USD2,157,388USD—279,091,534USD-276,000,000USD
Sale Purchase Of Stock—-1,802,869USD-10,657,185USD-700,000USD—
Investments——-819,000USD0USD—
Unclassified Financing Cash Flow———273,040,913USD283,072,107USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

No revenue breakdown is currently published for this company.

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.